期刊文献+

子宫恶性混合性苗勒管肿瘤32例临床特征分析 被引量:1

Clinical Analysis of 32 Cases of Uterine Malignant Mullerian Mixed Tumor
下载PDF
导出
摘要 目的:分析子宫恶性混合性苗勒管肿瘤(MMMT)的临床特点、诊断、治疗及影响预后的相关因素。方法:回顾性分析西安交通大学第一附属医院2008年1月至2018年1月收治的32例子宫MMMT(1例子宫颈MMMT,31例子宫体MMMT)的临床资料,并对影响子宫MMMT的3年生存率的相关因素行Cox回归分析。结果:①患者平均年龄58.2±5.6岁,71.9%(23/32)为绝经后妇女。93.8%(30/32)表现为不规则阴道流血。77.8%(21/27)术前肿瘤标志物(NSE、CA_(125)、CA_(724)、CA_(199)等)有不同程度升高,多表现为轻度增高。②44.4%(12/27)术前诊断性刮宫病理检查结果与术后病理学诊断相符。93.3%(14/15)的盆腔MRI检查可实现术前早期诊断。③所有患者均行手术治疗,术后26例行化疗,3例接受放疗。④随访6~125个月。子宫体MMMTⅠ期患者1、3、5年总生存率分别为95.3%、61.9%、42.9%,Ⅱ、Ⅲ、Ⅳ期患者1、3、5年总生存率分别为80.0%、50.0%、30.0%。⑤Cox多因素分析示,肿瘤浸润子宫肌层深度≥1/2是影响生存的独立危险因素(OR 5.102,P=0.018)。结论:子宫MMMT多发生于绝经后妇女,预后差,临床表现多为阴道不规则流血,实验室检查肿瘤标志物轻度升高无特异性,术前行盆腔MRI检查联合诊刮可提高术前诊断率,早期及晚期患者5年生存率均低于50%,且肿瘤浸润子宫肌层深度≥1/2是影响生存的独立危险因素。 Objective:To analyze the clinical characteristics,diagnosis,treatment and prognostic factors of Uterine malignant Mullerian mixed tumor(MMMT).Methods:The clinical data of 32 cases of MMMT(1 case of cervical MMMT and 31 cases of uterine body MMMT) admitted in the First Affiliated Hospital of Xi′an Jiaotong University from January 2008 to January 2018 were retrospectively analyzed.The Cox regression analysis was performed on the related factors affecting the 3-year survival rate of MMMT.Results:①The mean age of patients was 58.2±5.6 years old.71.9%(23/32) were postmenopausal women.93.8%(30/32) showed irregular vaginal bleeding.77.8%(21/27)were with increased preoperative tumor markers(NSE,CA125,CA724,CA199,etc.),mostly with slight increase.②The diagnostic curettage pathological results before the operation was consistent with the postoperative pathological diagnosis in 44.4% of patients(12/27).93.3%(14/15) could be diagnosed by pelvic MRI preoperatively.③All patients received surgical treatment.26 patients received chemotherapy and 3 patients received radiotherapy after surgery.④Postoperative follow-up lasted 6-125 months.The 1,3,5 year overall survival rates were 95.3%,61.9%,42.9% in patients with stage Ⅰ uterine body MMMT,respectively.The 1,3,5 year overall survival rates of patients with stage Ⅱ/Ⅲ/Ⅳ were 80.0%、50.0%、30.0%,respectively.⑤Cox multivariate analysis indicated that tumor infiltration depth of myometrium more than 1/2 was an independent risk factors of survival rate(OR 5.102,P=0.018).Conclusions:MMMT often occurs in postmenopausal women with poor prognosis.The most common clinical manifestation is irregular vaginal bleeding.There is no specific laboratory examination with only a few tumor markers slightly elevated.Preoperatively pelvic MRI combined with curettage diagnosis could improve the preoperative diagnostic rate.5 year survival rate in both early or late stage was lower than 50%.The tumor infiltration depth of myometrium more than 1/2 was an independent risk factor affecting survival rate.
作者 侯萌 曾宪玲 薛艳 安瑞芳 HOU Meng;ZENG Xianling;XUE Yan(Department of Obstetrics and Gynecology,First Affiliated Hospital of Xi'an Jiaotong University,Xi'an Shanxi 710061,China)
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2019年第2期150-154,共5页 Journal of Practical Obstetrics and Gynecology
关键词 子宫肿瘤 恶性混合性苗勒管肿瘤 生存率 预后 Uterine tumor Malignant Mullerian mixed tumor Survival rates Progno stic factors
  • 相关文献

参考文献3

二级参考文献20

  • 1曹剑,李胜泽,刘雅莉,杨克虎.盆腔淋巴结清扫术对Ⅰ期子宫内膜癌的疗效研究[J].实用癌症杂志,2010,25(5):483-486. 被引量:8
  • 2杨越波,李小毛,向阳.子宫肿瘤[M].北京:人民军医出版社,2011:193.
  • 3GADDUCCI A, COSIO S, ROMANINI A, et al. The management of patients with uterine sarcoma: a debated clinical challenge[J]. Crit Rev Oncol Hematol, 2008, 65(2) : 129 -142.
  • 4HOSKINS P J, LE N. Preoperative tumor markers at diagnosis in women with malignant mixed mullerian tumors/ the uterus[J]. Int J Gynecol Cancer, 2008, 18 (6) : 1200 - 1201.
  • 5KERNOCHAN L E, GARCIA R L. Carcinosarcomas (malignant mixed Mullerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics[J]. J Natl Compr Canc Netw, 2009, 7(5) : 550 -556, quiz 557.
  • 6AMANT F, CADRON I, FUSO L, et al. Endometrial carcinosar- comas have a different prognosis and pattern of spread compared to high- risk epithelial endometrial cancer [ J]. Gynecol Oncol, 2005, 98 (2) : 274 - 280.
  • 7ANTONSEN S L, HOGDALL E, CHRISTENSEN I J, et al. HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET) [ J ]. Acta Obstet Gynecol Scand, 2013, 92 ( 11 ) : 1313 - 1322.
  • 8舒珊荣,李小毛,柯佩琪.子宫内膜癌手术治疗的进展[J].中山大学研究生学刊(自然科学与医学版),2009,30(1):21-24. 被引量:5
  • 9李小毛,叶辉霞.非子宫内膜样腺癌组织学类型及临床特点[J].广东医学,2010,31(22):2997-3000. 被引量:8
  • 10李小毛,叶辉霞.子宫内膜样腺癌病理及临床特点[J].广东医学,2010,31(21):2859-2860. 被引量:15

共引文献18

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部